|
Welcome to Investor Relations, your source for insight into the investor information of Stem Cell Therapy International (“SCII”).
The Investor Relation Section is intended to assist investors to better understand our business strategies and our financial results.
As you navigate through the Investor Relations Sections and other areas of SCII’s site, you will be able to gain an understanding of our products, research and services that differentiate us from our competitors.
We will continuously add new information to the site to bring increased awareness of our business strategies and financial progress. We welcome your feedback and if you would like additional information or would like to speak to us, please go to contact us and complete the information and we will get back with you soon.
Andrew J. Norstrud, CFO
email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Contact AmStem |
Stem Cell Investor News
